Pharmagen, Inc.
PHRX
$0.00
$0.000.00%
OTC PK
| 03/31/2014 | 12/31/2013 | 09/30/2013 | 06/30/2013 | 03/31/2013 | |
|---|---|---|---|---|---|
| Net Income | -5.87M | -6.00M | -4.61M | -4.30M | -3.27M |
| Total Depreciation and Amortization | 110.90K | 99.30K | 73.60K | 56.50K | 40.90K |
| Total Amortization of Deferred Charges | 2.53M | 2.57M | 2.27M | 1.67M | 1.17M |
| Total Other Non-Cash Items | 758.90K | 955.90K | -40.40K | 361.10K | -264.40K |
| Change in Net Operating Assets | 1.99M | 1.69M | 873.30K | 1.04M | 352.60K |
| Cash from Operations | -483.10K | -692.10K | -1.43M | -1.16M | -1.97M |
| Capital Expenditure | -102.60K | -56.70K | -32.50K | -64.20K | -105.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -80.00K | -80.00K | -80.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -102.60K | -56.70K | -112.50K | -144.20K | -185.80K |
| Total Debt Issued | 196.30K | 755.50K | 1.94M | 1.86M | 2.85M |
| Total Debt Repaid | -217.80K | -192.70K | -220.70K | -318.10K | -56.80K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 225.00K | 125.00K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -35.50K | -35.50K | -35.50K | -35.50K |
| Cash from Financing | 203.50K | 652.30K | 1.69M | 1.50M | 2.76M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -382.30K | -96.60K | 143.80K | 196.50K | 606.80K |